Give Your Patients the Next Level of Symptomatic Relief with Karbinal™ ER

Karbinal™ ER (carbinoxamine maleate) is an H1 receptor antagonist indicated for the symptomatic treatment of:

  • Seasonal and perennial allergic rhinitis.
  • Vasomotor rhinitis.
  • Allergic conjunctivitis due to inhalant allergens and foods.
  • Mild, uncomplicated allergic skin manifestations of urticaria and angioedema.
  • Dermatographism.
  • As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.
  • Amelioration of the severity of allergic reactions to blood or plasma.

Karbinal™ ER (carbinoxamine maleate) Extended-release Oral Suspension provides symptomatic relief of seasonal and perennial allergic rhinitis in children as young as 2 years old.